Patients are the heart of our science
ONCOLOGY
We focus on improving the health outcomes of people living with cancer. With more than 35 years of oncology experience, we are driven by a strong sense of purpose: to support patients’ lives, improve health outcomes and create a positive impact for patients and society.
RARE DISEASE
Pioneering rare disease treatments – Ipsen
Ninety-four percent of rare medical conditions still have no treatment. Today our Rare Disease teams are more committed than ever to changing that. We leverage scientific expertise, our global presence, and a robust external innovation strategy, plus first-in-the-world clinical trials to develop life-changing rare disease therapeutics.
NEUROSCIENCE
Ipsen is a global leader in neuroscience and toxins research for neuromuscular treatments.
Neuroscience is advancing at an unprecedented rate, and we are proud to be at the forefront of this transformation. Our focus is on enabling children and adults suffering from debilitating and degenerative neuromuscular disorders. Our long‐term commitment to advancing neuroscience and toxins research is evidenced by 30 years of clinical experience.
Neuroscience is central to Ipsen’s internal innovation and external partnering, integral to the company’s overall strategy, and a key driver of long‐term value and growth.